수술적 치료를 받은 골다공증성 원위 요골 골절 환자에서 경구용 및 정주용 Bisphosphonate의 사용이 미치는 영향
Influence of Oral and Intravenous Bisphosphonate for the Patients Treated Surgically in Osteoporotic Distal Radius Fracture
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Purpose of this study is investigation the influence of intravenous and oral bisphosphonate to bone union and clinical results in patient treated with plate fixation in an osteoporotic distal radius fracture. Materials and Methods: The medical records of 160 patients with an osteoporotic distal radius fracture treated with plate fixation in our hospital between January 2008 and April 2012 were reviewed retrospectively. The patients were classified by 3 groups; who did not administrate bisphosphonate after surgery as Group I (n=69), administrated oral bisphosphonate after surgery as Group II (n=44), and administrated intravenous bisphosphonate as Group III (n=47). After surgery, bone union, radiologic parameters, disabilities of the DASH score and range of motion of wrist were assessed. Results: Mean time of bone union was 6.7 weeks in Group I, 6.8 weeks in Group II, and 7.1 weeks in Group III. There was no significant difference between three groups (P=0.571). Bone union rate on 6weeks shows no significant differences between three groups (P=0.16). Three groups also have no significant differences in all radiologic and clinical parameters. Conclusion: This study shows that early initiation of oral and Intravenous bisphosphonate did not affect bone union and clinical results compared to group who did not administrate bisphosphonate result in patient treated with plate fixation in an osteoporotic distal radius fracture.
Abstract
Objectives: Purpose of this study is investigation the influence of intravenous and oral bisphosphonate to bone union and clinical results in patient treated with plate fixation in an osteoporotic distal radius fracture. Materials and Methods: The medical records of 160 patients with an osteoporotic distal radius fracture treated with plate fixation in our hospital between January 2008 and April 2012 were reviewed retrospectively. The patients were classified by 3 groups; who did not administrate bisphosphonate after surgery as Group I (n=69), administrated oral bisphosphonate after surgery as Group II (n=44), and administrated intravenous bisphosphonate as Group III (n=47). After surgery, bone union, radiologic parameters, disabilities of the DASH score and range of motion of wrist were assessed. Results: Mean time of bone union was 6.7 weeks in Group I, 6.8 weeks in Group II, and 7.1 weeks in Group III. There was no significant difference between three groups (P=0.571). Bone union rate on 6weeks shows no significant differences between three groups (P=0.16). Three groups also have no significant differences in all radiologic and clinical parameters. Conclusion: This study shows that early initiation of oral and Intravenous bisphosphonate did not affect bone union and clinical results compared to group who did not administrate bisphosphonate result in patient treated with plate fixation in an osteoporotic distal radius fracture.
참고문헌 (18)
- Löfman O, "Women with lowenergy fracture should be investigated for osteoporosis", Acta Orthop, 78, pp.813~821 (2007)
- Mallmin H, "Distal radius fracture is an early sign of general osteoporosis: bone mass measurements in a population-based study", Osteoporos Int, 4, pp.357~361 (1994)
- Black DM, "Once yearly zoledronic acid for treatment of postmenopausal osteoporosis", N Engl J Med, 356, pp.1809~1822 (2007)
- Li C, "Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats", J Bone Miner Res, 16, pp.429~436 (2001)
- Cao Y, "Raloxifen, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats", J Bone Miner Res, 17, pp.2237~2246 (2002)
- Lee YK, "Incidence of second hip fracture and compliant use of bisphosphonate", Osteoporos Int, 24, pp.2099~2104 (2013)
- Gong GS, "Eerly Initiation of Bisphosphonate does not affect healing and outcomes of volar plate fixation of osteporotic distal radial fracutures", J Bone Joint Surg Am, 94, pp.1729~1736 (2012)
- Charles AG, "Wrist fractures: what the clinical want to know", Radiology, 219, pp.11~28 (2001)
- . The upper extremity collaborative Group(UECG), "Am J Ind Med", 1996, 602~608
- 조명래, "고관절부, 요추부, 원위 요골에서의 골밀도에 따른 골다공증 진단의 일치도", Hip and Pelvis, 24(1), pp.53~58 (2012), 대한고관절학회
- Odvina CV, "Severely suppressed bone turnover: a potential complication of alendronate theraphy", J Clin Endocrinol Metab, 90, pp.1294~1301 (2005)
- Goodship AE, "Use of a bisphosphosnate (pamidronate) to modulate fracture repair in ovine bone", Ann Oncol, 5(Suppl 7), pp.S53~S55 (1994)
- Little DG, "Maipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect modal", J Bond Miner Res, 20, pp.2044~2052 (2005)
- Amanat N, "A single systemic dose of strength in a rat model of fracture repair", J Orthop Res, 23, pp.1029~1034 (2005)
- Amanat N, "Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair", J Bone Miner Res, 22, pp.867~876 (2007)
- Fleisch H., "Can bisphosphonate be given to patient with fractures", J Bone Minor Res, 16, pp.437~440 (2001)
- 이영균, "수술적 치료를 받은 고관절 주위 골절 환자에서의 정주용 Bisphosphonate : 단기 안전성에 대한 전향적 코호트 연구", Hip and Pelvis, 20(4), pp.305~310 (2008), 대한고관절학회
- Lyles KW, "Zoledronic acid and clinical fratures and mortality after hip fracture", N Engle J Med, 357, pp.1799~1809 (2007)